WGRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Wellgistics Health Inc (WGRX) is not a strong buy at the moment for a beginner, long-term investor. The lack of positive trading signals, poor financial performance, and bearish technical indicators suggest waiting for clearer signs of growth or stability before investing.
The MACD is slightly positive, but RSI is neutral at 26.76, indicating no clear momentum. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below key support levels (S1: 0.114). Overall, the technical outlook is bearish.
The announcement of a potential $105 million all-stock acquisition of Neuritek Therapeutics could enhance Wellgistics' healthcare platform. The company is also exploring additional strategic opportunities, which may drive future growth.
The acquisition is non-binding and subject to due diligence and approvals, introducing uncertainty. Financial performance in 2025/Q4 was extremely poor, with revenue dropping -86.54% YoY and gross margin at -518.27%.
In 2025/Q4, revenue dropped significantly by -86.54% YoY to $1,670,648. Net income improved but remains negative at -$27,852,959. EPS increased to -0.29, but gross margin deteriorated drastically to -518.27%. Overall, the financials indicate poor performance and instability.
No analyst rating or price target changes are available for WGRX at this time.
